Trajectories of biomedical research leading to Nobel Prize–winning discoveries

Author:

Burnett Wendy J.1,Balas E. Andrew12,Heboyan Vahe2,Matthews Kirstin R. W.3

Affiliation:

1. Biomedical Research Innovation Laboratory Augusta University Augusta Georgia USA

2. School of Public Health Augusta Georgia USA

3. Baker Institute for Public Policy Rice University Houston Texas USA

Abstract

AbstractSignificant advancements in public health come from scientific discoveries, but more are needed to meet the ever‐growing societal needs. Examining the best practices of outstanding scientists may help develop future researchers and lead to more discoveries. This study compared the comprehensive work of 49 Nobel laureates in Physiology or Medicine from 2000 to 2019 to a matched control of National Institutes of Health (NIH)‐funded biomedical investigators. Our unique data set, comprising 11,737 publications, 571 US patents, and 1693 NIH research awards produced by pre‐Nobel laureates, was compared to a similar data set of control researchers. Compared to control researchers, pre‐Nobel laureates produce significantly more publications annually (median = 5.66; interquartile range [IQR] = 5.16); significantly fewer coauthors per publication (median = 3.32; IQR = 1.95); consistently higher Journal Impact Factor publications (median = 12.04; IQR = 6.83); and substantially more patents per researcher (median = 5; IQR = 14). Such differences arose from nearly identical cumulative NIH award budgets of pre‐Nobel laureates (median $25.3 M) and control researchers. Nobel laureates are neither hyper‐prolific (>72 papers per year) nor hyper‐funded (>$100 M cumulative). An academic age–specific trajectory graph allows aspiring researchers to compare their productivity and collaboration patterns to those of pre‐Nobel laureates.

Funder

National Institute of General Medical Sciences

Publisher

Wiley

Reference38 articles.

1. Of Nobel class: A citation perspective on high impact research authors

2. Characterizing the publications of eminent scientists: The case of nobel laureates in Medicine;Amin R.;Advance and Innovative Research,2021

3. Garfield E.(1998).The use of journal impact factors and citation analysis for evaluation of science. In41st Annual Meeting of the Council of Biology Editors.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3